GLP-1 Market
LLY $1351.12 ▼ -2.3% NVO $38.87 ▼ -1.4% PFE $27.54 ▼ -1.9% VKTX $25.84 ▼ -1.3% KLRA $11.58 ▼ -1.8% GPCR $17.12 ▼ -1.4% RHHBY $58.99 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Alendronate Sodium

Company
Odense University Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
7 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

7 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026

Find a Clinical Trial Near Me

See recruiting studies for Alendronate Sodium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04704947

    Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

    Not yet reported Sherief Abd-Elsalam 50 participants Est. completion 2030-10-01 1 site Stand-alone
    Other conditions: Beta Blocker Toxicity
    View official trial listing →
  • Recruiting NCT NCT05527548

    A Multi-centre, Double-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLR

    Not yet reported Chinese University of Hong Kong 100 participants Est. completion 2028-07-22 1 site Stand-alone
    Other conditions: ACL Reconstruction
    View official trial listing →
  • Recruiting NCT NCT05764733

    Bone, Exercise, Alendronate, and Caloric Restriction

    Not yet reported Wake Forest University Health Sciences 900 participants Est. completion 2028-01 2 sites Stand-alone
    Other conditions: Bone Loss
    View official trial listing →
  • Recruiting NCT NCT06016634

    Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

    Not yet reported University of California, Davis 30 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Sickle Cell Anemia, Osteonecrosis, Ischemic Necrosis, Avascular Necrosis
    View official trial listing →
  • Recruiting NCT NCT06864130

    A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures

    Not yet reported Odense University Hospital 1400 participants Est. completion 2029-09-15 8 sites Stand-alone
    Other conditions: Osteoporosis in Post-menopausal Women
    View official trial listing →
  • Recruiting NCT NCT07216794

    Small Trial of Alendronate Impact on the Reservoir of HIV

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 2027-05-21 5 sites Stand-alone
    Other conditions: HIV
    View official trial listing →
  • Recruiting NCT NCT07435051

    Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 280 participants Est. completion 2030-12-31 1 site Stand-alone
    Other conditions: Osteomyelitis (Refractory)
    View official trial listing →
  • Completed NCT NCT00000400

    Alendronate and/or Parathyroid Hormone for Osteoporosis

    Not yet reported Massachusetts General Hospital 176 participants Est. completion 2006-06 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00000412

    Osteoporosis Prevention After Heart Transplant

    Not yet reported Columbia University 149 participants Est. completion 2002-04 2 sites
    Other conditions: Osteoporosis, Cardiac Transplantation
    View official trial listing →
  • Completed NCT NCT00000427

    Effects of Parathyroid Hormone in Men With Osteoporosis

    Not yet reported Massachusetts General Hospital 81 participants Est. completion 2005-10 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00000430

    Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 240 participants Est. completion 2004-09 1 site
    Other conditions: Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00001720

    Treatment of Childhood Osteoporosis With Alendronate (Fosamax)

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 50 participants Est. completion 2003-06 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00001728

    Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 40 participants Est. completion 2011-05-02 1 site
    Other conditions: Polyostotic Fibrous Dysplasia
    View official trial listing →
  • Completed NCT NCT00004488

    Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 82 participants Est. completion 2002-09 3 sites
    Other conditions: Gaucher's Disease, Osteopenia
    View official trial listing →
  • Completed NCT NCT00004489

    Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis

    Not yet reported University of North Carolina 60 participants Est. completion 2002-09 1 site
    Other conditions: Osteoporosis, Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00005005

    PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

    Not yet reported Dennis Black 238 participants Est. completion 2007-11 4 sites Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00005006

    Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

    Not yet reported Helen Hayes Hospital 140 participants Est. completion 2006-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00006180

    Bone Loss in Premenopausal Women With Depression

    Not yet reported National Institute of Mental Health (NIMH) 220 participants Est. completion 2007-01-19 1 site
    Other conditions: Depression, Healthy, Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00010439

    Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

    Not yet reported Medical University of South Carolina 10 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00019695

    Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2005-03 1 site
    Other conditions: Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00035971

    EVA: Evista Alendronate Comparison

    Not yet reported Eli Lilly and Company 86 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00043186

    Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

    Not yet reported Amgen 412 participants Est. completion 2007-06
    Other conditions: Low Bone Mineral Density
    View official trial listing →
  • Completed NCT NCT00048841

    Prevention of Osteoporosis in Men With Prostate Cancer

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 112 participants Est. completion 2005-12 1 site
    Other conditions: Prostate Cancer, Osteoporosis, Hypogonadism
    View official trial listing →
  • Completed NCT NCT00051558

    Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis

    Not yet reported Eli Lilly and Company 428 participants Est. completion 2008-01 15 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00061256

    The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 80 participants Est. completion 2006-09 28 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00079924

    Effects of Teriparatide in Postmenopausal Women With Osteoporosis

    Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-05 10 sites
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00092014

    A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)

    Not yet reported Organon and Co 1053 participants Est. completion 2004-04-01 Stand-alone
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00092027

    A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)

    Not yet reported Organon and Co 454 participants Est. completion 2004-03-15
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00092040

    A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

    Not yet reported Organon and Co 936 participants Est. completion 2005-09-28
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00092066

    A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

    Not yet reported Organon and Co 717 participants Est. completion 2004-05-01
    Other conditions: Osteoporosis, Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT00092079

    A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

    Not yet reported Merck Sharp & Dohme LLC 652 participants Est. completion 2004-11
    Other conditions: Osteoporosis, Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT00120757

    Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)

    Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 140 participants Est. completion 2008-11 3 sites
    Other conditions: Osteoporosis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00122356

    Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment

    Not yet reported Barwon Health 303 participants Est. completion 2013-03 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00130403

    OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

    Not yet reported Sanofi 290 participants Est. completion 2007-03 7 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00136058

    Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

    Not yet reported University of Alberta 250 participants Est. completion 2006-04 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00138983

    Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

    Not yet reported UMC Utrecht 200 participants Est. completion 2003-11 1 site
    Other conditions: Rheumatoid Arthritis, Polymyalgia Rheumatica, Giant Cell Arteritis, Polymyositis, Wegener's Granulomatosis
    View official trial listing →
  • Completed NCT NCT00145977

    Texture Analysis for Postmenopausal Osteoporosis

    Not yet reported University of Chicago 36 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Osteoporosis, Osteopenia
    View official trial listing →
  • Completed NCT NCT00157690

    Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients

    Not yet reported McMaster University 56 participants Est. completion 2006-08 6 sites
    Other conditions: Cystic Fibrosis, Osteoporosis, Bone Diseases, Metabolic
    View official trial listing →
  • Completed NCT NCT00159419

    Bisphosphonate Therapy for Osteogenesis Imperfecta

    Not yet reported Indiana University 18 participants Est. completion 2008-08
    Other conditions: Osteogenesis Imperfecta, Osteoporosis, Paget Disease of Bone
    View official trial listing →
  • Completed NCT NCT00168909

    Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)

    Not yet reported Charite University, Berlin, Germany 282 participants Est. completion 2008-05 2 sites
    Other conditions: Osteoporosis, Postmenopausal, Osteopenia, Falls
    View official trial listing →
  • Completed NCT NCT00177619

    Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

    Not yet reported University of Pittsburgh 120 participants Est. completion 2005-12 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00191893

    Bone Effects of Teriparatide Following Alendronate

    Not yet reported Eli Lilly and Company 66 participants Est. completion 2006-11 2 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00209469

    Network Osteoporosis Study

    Not yet reported, Not yet reported Glaser Pediatric Research Network 90 participants Est. completion 2007-02 4 sites
    Other conditions: Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00221312

    Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

    University of California, San Francisco 48 participants Est. completion 2007-07 1 site
    Other conditions: Perimenopausal Bone Loss
    View official trial listing →
  • Terminated NCT NCT00236002

    Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

    Not yet reported Canadian Urology Research Consortium 182 participants Est. completion 2009-08
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00259857

    Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

    Not yet reported Medical University of South Carolina 22 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00261625

    Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?

    Not yet reported National Taiwan University Hospital 50 participants Est. completion 2007-10
    Other conditions: End-Stage Renal Disease, Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00265252

    Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 60 participants Est. completion 2008-06 1 site
    Other conditions: Non-Traumatic Osteonecrosis
    View official trial listing →
  • Completed NCT NCT00277251

    Alendronate Osteoporosis Study

    Not yet reported, Not yet reported Boston Children's Hospital 20 participants Est. completion 2006-06
    Other conditions: Glucocorticoid-Associated Osteopenia and Osteoporosis
    View official trial listing →
  • Completed NCT NCT00293813

    A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

    Not yet reported Amgen 247 participants Est. completion 2008-08 Stand-alone
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00297830

    Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

    Not yet reported, Not yet reported Columbia University 111 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Heart Transplantation, Liver Transplantation, Bone Resorption
    View official trial listing →
  • Status unknown NCT NCT00299572

    Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?

    Not yet reported Far Eastern Memorial Hospital 50 participants Est. completion 2006-12 1 site
    Other conditions: Peritoneal Dialysis
    View official trial listing →
  • Completed NCT NCT00327990

    Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

    Not yet reported GlaxoSmithKline 300 participants Est. completion 2006-12 38 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00330460

    A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

    Not yet reported Amgen 1189 participants Est. completion 2008-01
    Other conditions: Osteoporosis, Osteopenia
    View official trial listing →
  • Status unknown NCT NCT00346190

    The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 10 participants Est. completion 2007-04 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00354302

    Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

    Not yet reported NCIC Clinical Trials Group 497 participants Est. completion 2012-01-06 13 sites
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Withdrawn NCT NCT00359385

    The Effects of Alendronate After Cure of Primary Hyperparathyroidism

    Not yet reported Columbia University Est. completion 2009-09 1 site
    Other conditions: Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT00377819

    Study of Transitioning From Alendronate to Denosumab

    Not yet reported Amgen 504 participants Est. completion 2008-07
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00389740

    A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

    Not yet reported Organon and Co 400 participants Est. completion 2003-01-16
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT00391404

    Fosamax for Childhood Cancer Survivors

    Not yet reported Chinese University of Hong Kong 100 participants Est. completion 2008-10 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00395382

    Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease

    Not yet reported Monash University 50 participants Est. completion 2009-09 1 site
    Other conditions: Vascular Calcification, Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00398606

    A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

    Not yet reported Organon and Co 650 participants
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00398931

    FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

    Not yet reported Organon and Co 1099 participants Est. completion 2003-10
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00400530

    Upper GI Handling of Branded vs. Generic Alendronate

    Not yet reported Merck Sharp & Dohme LLC 25 participants
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00404820

    Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis

    Not yet reported Novartis 604 participants Est. completion 2008-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00421343

    Secondary Prevention of Osteoporosis

    Not yet reported Hebrew SeniorLife 29 participants Est. completion 2008-06 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00460057

    The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

    Not yet reported Eulji University Hospital 63 participants Est. completion 2007-02
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00463268

    Osteoporosis Prevention With Low Dose Alendronate

    Not yet reported University Hospital of Mont-Godinne 83 participants Est. completion 2012-01 1 site
    Other conditions: Osteopenia
    View official trial listing →
  • Terminated NCT NCT00471237

    A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

    Not yet reported GlaxoSmithKline 564 participants Est. completion 2008-12-26 49 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00480662

    A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)

    Not yet reported Organon and Co 60 participants Est. completion 2002-10
    Other conditions: Paget's Disease of Bone
    View official trial listing →
  • Completed NCT NCT00480766

    A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)

    Not yet reported Organon and Co 173 participants Est. completion 2003-08
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00503113

    A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

    Not yet reported Hoffmann-La Roche 801 participants Est. completion 2010-04 44 sites
    Other conditions: Post-Menopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00504166

    Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women

    Not yet reported University of California, San Francisco 53 participants Est. completion 2009-04 1 site
    Other conditions: Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00518531

    Denosumab Adherence Preference Satisfaction Study

    Not yet reported Amgen 250 participants Est. completion 2010-06-01
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00532337

    Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis

    Not yet reported Ono Pharma USA Inc 285 participants 1 site
    Other conditions: Osteoporosis, Osteopenia
    View official trial listing →
  • Completed NCT NCT00545779

    BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

    Not yet reported Hoffmann-La Roche 677 participants Est. completion 2008-10 32 sites
    Other conditions: Post-Menopausal Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00572299

    Glucocorticoids Promote Osteoclast Survival

    University of Arkansas 3 participants Est. completion 2010-05 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00577850

    Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

    Not yet reported Warner Chilcott 32 participants Est. completion 2004-02 2 sites
    Other conditions: Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00580047

    Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

    Not yet reported University of Nebraska 59 participants Est. completion 2014-07-29 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00593580

    Bone Health in Gynecologic Cancers-does FOSAVANCE Help?

    Not yet reported British Columbia Cancer Agency 60 participants Est. completion 2011-06 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00601068

    Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis

    University of Florida 35 participants Est. completion 2011-07 1 site
    Other conditions: Osteonecrosis
    View official trial listing →
  • Completed NCT NCT00641771

    4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

    Not yet reported Organon and Co 56 participants Est. completion 2005-08 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00666627

    Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

    Not yet reported Sheffield Teaching Hospitals NHS Foundation Trust 410 participants Est. completion 2014-12 1 site
    Other conditions: Post-menopausal Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00668941

    Cyclic Versus Daily Teriparatide on Bone Mass

    Not yet reported Helen Hayes Hospital 140 participants Est. completion 2017-11 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00680953

    Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis

    Not yet reported Daiichi Sankyo Co., Ltd. 1262 participants Est. completion 2012-07 4 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00692913

    A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)

    Not yet reported Organon and Co 515 participants Est. completion 2010-07 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00713258

    The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)

    Not yet reported Nycomed 75 participants Est. completion 2010-09 1 site
    Other conditions: Back Pain
    View official trial listing →
  • Status unknown NCT NCT00727493

    Osteoporosis and Dental Implant

    Not yet reported Charite University, Berlin, Germany 45 participants Est. completion 2010-04 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00729651

    Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

    Not yet reported Organon and Co 343 participants Est. completion 2009-04-10 Stand-alone
    Other conditions: Osteoporosis Postmenopausal
    View official trial listing →
  • Completed NCT NCT00739466

    Biorest Liposomal Alendronate With Stenting sTudy (BLAST)

    Not yet reported BIOrest Ltd. 226 participants Est. completion 2015-12 12 sites Stand-alone
    Other conditions: Coronary Artery Stenosis
    View official trial listing →
  • Completed NCT NCT00778154

    Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

    Warner Chilcott 105 participants Est. completion 2006-12 8 sites
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00803790

    A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)

    Not yet reported Organon and Co 318 participants Est. completion 2006-07 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00806416

    A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D

    Not yet reported Organon and Co 244 participants Est. completion 2004-01 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00822029

    Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

    Not yet reported Department of Clinical Research and Innovation 2 participants Est. completion 2011-02 1 site
    Other conditions: Osteoporosis, Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT00835406

    Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

    Not yet reported Teva Pharmaceuticals USA 140 participants Est. completion 2000-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00885170

    A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)

    Not yet reported Merck Sharp & Dohme LLC 246 participants Est. completion 2011-09-15
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00891553

    CR9112792, a Follow-up of Study CR9108963

    GlaxoSmithKline 171 participants Est. completion 2009-06 3 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00896532

    Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

    Not yet reported Amgen 419 participants Est. completion 2016-02-18
    Other conditions: Low Bone Mineral Density, Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT00919711

    Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

    Not yet reported Amgen 870 participants Est. completion 2012-03-05
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00920075

    Alendronate in Juvenile Osteoporosis

    Medical University of South Carolina 11 participants Est. completion 2010-10 1 site
    Other conditions: Juvenile Osteoporosis, Low Bone Density, Fractures
    View official trial listing →
  • Completed NCT NCT00921557

    Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2017-01 10 sites Stand-alone
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT00936260

    Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

    Not yet reported Ciudad Universitaria, Spain 228 participants Est. completion 2004-12 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00983996

    Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)

    Not yet reported Mylan Pharmaceuticals Inc 112 participants Est. completion 2002-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00996801

    MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

    Not yet reported Merck Sharp & Dohme LLC 526 participants Est. completion 2011-06 Stand-alone
    Other conditions: Osteoporosis, Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT01012934

    Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

    Not yet reported Mylan Pharmaceuticals Inc 110 participants Est. completion 2002-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01020253

    The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)

    Not yet reported Yokohama City University Medical Center 60 participants 1 site
    Other conditions: Bone Density, Arthroplasty, Replacement, Hip
    View official trial listing →
  • Completed NCT NCT01065779

    FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

    Organon and Co 880 participants Est. completion 2010-07
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01077817

    Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

    Organon and Co 684815 participants Est. completion 2012-02-16
    Other conditions: Esophageal Cancer, Squamous Cell Carcinoma, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01101048

    An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density

    Not yet reported Amgen 74 participants Est. completion 2012-02
    Other conditions: Osteopenia
    View official trial listing →
  • Completed NCT NCT01104987

    Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS)

    Göteborg University 16 participants Est. completion 2016-07 1 site
    Other conditions: Ankylosing Spondylitis, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01128257

    A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

    Hoffmann-La Roche 6054 participants Est. completion 2011-12 1 site
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Terminated NCT NCT01131884

    Pilot Study of Fosamax in Spinal Cord Injury

    Not yet reported University of Rochester 1 participants Est. completion 2012-12 2 sites
    Other conditions: Spinal Cord Injury, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01133496

    Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited, India 80 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01265615

    Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

    Not yet reported Ural State Medical University 109 participants Est. completion 2010-09 2 sites
    Other conditions: Cardiorenal Syndrome, Chronic Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT01350934

    A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

    Not yet reported Organon and Co 219 participants Est. completion 2013-01-10 Stand-alone
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT01406613

    Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis

    Sheffield Teaching Hospitals NHS Foundation Trust 86 participants Est. completion 2015-11 1 site
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT01415050

    Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal Women

    Not yet reported X-pert Med GmbH 80 participants Est. completion 2011-07 5 sites
    Other conditions: Osteoporosis in Post-menopausal Women
    View official trial listing →
  • Completed NCT NCT01437111

    Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)

    Not yet reported Organon and Co 200 participants Est. completion 2012-12-05 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT01460654

    Testosterone and Alendronate in Hypogonadal Men

    Not yet reported Massachusetts General Hospital 44 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Hypogonadism, Osteopenia, Osteoporosis
    View official trial listing →
  • Terminated NCT NCT01512446

    Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

    Not yet reported Evangelisches Krankenhaus Lutherhaus gGmbH 436 participants Est. completion 2013-03 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01526278

    Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women

    Not yet reported Yuyu Pharma, Inc. 18 participants Est. completion 2012-09 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01535027

    Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

    Not yet reported Medical University of Vienna 125 participants Est. completion 2012-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Withdrawn NCT NCT01552122

    Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

    Not yet reported Merck Sharp & Dohme LLC Est. completion 2015-02 Stand-alone
    Other conditions: Osteoporosis, Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT01588509

    Transition From Alendronate to Romosozumab (AMG 785)

    Not yet reported Amgen 60 participants Est. completion 2012-11-21 9 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01631214

    Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

    Not yet reported Amgen 4093 participants Est. completion 2017-06-29 316 sites Stand-alone
    Other conditions: Postmenopausal Women With Osteoporosis
    View official trial listing →
  • Completed NCT NCT01648686

    Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly

    Not yet reported Assistance Publique - Hôpitaux de Paris 66 participants Est. completion 2015-11-05 1 site
    Other conditions: Alveolar Bone Healing After Dental Extraction
    View official trial listing →
  • Terminated NCT NCT01656629

    Stem Cell Recruitment in Osteoporosis Therapy

    Not yet reported Johns Hopkins University 55 participants Est. completion 2020-08-07 1 site
    Other conditions: Low Bone Density
    View official trial listing →
  • Completed NCT NCT01657162

    Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

    Not yet reported Radius Health, Inc. 1139 participants Est. completion 2016-10-03 25 sites Stand-alone
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT01750086

    Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

    Not yet reported Massachusetts General Hospital 27 participants Est. completion 2014-08 1 site
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT01770106

    RA Denosumab on Bone Microstructure Study

    Not yet reported Chinese University of Hong Kong 40 participants Est. completion 2014-06 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01812551

    Treatment of Low Bone Density in Cystic Fibrosis.

    Not yet reported Istituto Auxologico Italiano 171 participants Est. completion 2007-07 11 sites
    Other conditions: Osteoporosis, Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT01875458

    Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use

    University of Pennsylvania 314 participants Est. completion 2022-10-30 1 site
    Other conditions: Osteoporosis, With or Without Treatment, Bisphosphonate Treatment, Atypical Femur Fracture, Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ), Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01882400

    Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy

    Not yet reported Gilles Boire 11 participants Est. completion 2007-09 1 site
    Other conditions: Osteoporosis, Muscular Dystrophy, Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT01889134

    OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

    Not yet reported Wroclaw Medical University 112 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Primary Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT01968850

    Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial

    Not yet reported Unity Health Toronto 30 participants Est. completion 2018-03-19 2 sites Stand-alone
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02057263

    The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

    Not yet reported Massachusetts General Hospital 28 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT02132026

    Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.

    Not yet reported University of Edinburgh 152 participants Est. completion 2019-11-28 1 site
    Other conditions: Calcific Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT02139007

    Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

    Not yet reported University of Alabama at Birmingham 27 participants Est. completion 2016-07 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT02166437

    Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese

    Tomidahama Hospital 500 participants Est. completion 2018-11 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02168543

    1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers

    Not yet reported Government Dental College and Research Institute, Bangalore 46 participants Est. completion 2011-04 Stand-alone
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02195895

    Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

    Not yet reported Northwestern University 17 participants Est. completion 2016-08-05 1 site Stand-alone
    Other conditions: Spinal Cord Injury, Bone Loss, Osteoporosis
    View official trial listing →
  • Completed NCT NCT02230332

    Alendronate to Prevent Loss of Bronchoprotection in Asthma

    Not yet reported, Not yet reported Milton S. Hershey Medical Center 78 participants Est. completion 2016-09 10 sites Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02303873

    Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta

    Not yet reported Peking Union Medical College Hospital 99 participants Est. completion 2014-08 Stand-alone
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Completed NCT NCT02304757

    99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142 participants Est. completion 2019-12-30 1 site
    Other conditions: Differentiated Thyroid Cancer, Osteoporosis
    View official trial listing →
  • Terminated NCT NCT02322099

    Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

    Not yet reported University College Dublin 53 participants Est. completion 2019-09 2 sites
    Other conditions: Bone Demineralization
    View official trial listing →
  • Completed NCT NCT02371252

    Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment

    Not yet reported Mahidol University 140 participants Est. completion 2016-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02416271

    The Forteo Alendronate Comparator Trial

    Not yet reported Eli Lilly and Company 203 participants Est. completion 2003-05 20 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02417389

    Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism

    Not yet reported Istituto Auxologico Italiano 22 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Hyperparathyroidism, Primary, Osteoporosis
    View official trial listing →
  • Completed NCT NCT02440581

    Renal Osteodystrophy: An Individual Management Approach

    Not yet reported Hartmut Malluche, MD 141 participants Est. completion 2021-06-30 1 site Stand-alone
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT02445664

    Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment

    Not yet reported University of Southern Denmark 67 participants Est. completion 2014-11 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02455869

    Comparison of Alendronate With Atorvastatin in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 104 participants Est. completion 2015-03
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02461667

    Alendronate Compared to Metformin in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 108 participants Est. completion 2015-03
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02470611

    Sodium Alendronate in Non Surgical Periodontal Therapy

    Not yet reported Federal University of Minas Gerais 32 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Periodontitis, Bone Resorption
    View official trial listing →
  • Completed NCT NCT02516111

    Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 120 participants Est. completion 2015-05
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02518152

    Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2015-06 1 site
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02520362

    Denosumab Safety Assessment in Multiple Observational Databases

    Amgen 517991 participants Est. completion 2023-07-21
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02598440

    A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

    Not yet reported Hoffmann-La Roche 341 participants Est. completion 2005-05 54 sites Stand-alone
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT02598453

    PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

    Not yet reported Hoffmann-La Roche 545 participants Est. completion 2006-09 60 sites
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT02604836

    A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

    Not yet reported Hoffmann-La Roche 1711 participants Est. completion 2006-04 142 sites
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT02609061

    Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 72 participants Est. completion 2015-09 1 site
    Other conditions: Furcation Defects
    View official trial listing →
  • Status unknown NCT NCT02645799

    BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY

    Not yet reported BIOrest Ltd. 270 participants Est. completion 2018-11 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02731040

    Exome Sequencing for Atypical Femoral Fractures

    Washington University School of Medicine 38 participants Est. completion 2018-03-29
    Other conditions: Atypical Femoral Fractures, Osteoporosis, Bisphosphonate Therapy
    View official trial listing →
  • Terminated NCT NCT02781805

    Pilot Study of Bisphosphonates for Breast Cancer

    Not yet reported University of Wisconsin, Madison 6 participants Est. completion 2018-12-12 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02795546

    Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.

    Not yet reported Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 32 participants Est. completion 2016-04 Stand-alone
    Other conditions: Intrabony Periodontal Defect
    View official trial listing →
  • Completed NCT NCT02944799

    Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis

    Not yet reported University of Aarhus 69 participants Est. completion 2021-12-20 6 sites
    Other conditions: Rheumatoid Arthritis, Osteoporosis
    View official trial listing →
  • Completed NCT NCT03005678

    Denosumab Versus Bisphosphonates (Alendronate) in GIOP

    Not yet reported Tuen Mun Hospital 140 participants Est. completion 2020-02-01 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT03006003

    Osteoporosis Treatment in Post-menopausal Women

    Not yet reported Taichung Veterans General Hospital 500 participants Est. completion 2021-12 2 sites
    Other conditions: Depressive Syndrome
    View official trial listing →
  • Status unknown NCT NCT03040531

    Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis

    Not yet reported, Not yet reported University of Messina 200 participants Est. completion 2018-12-30 2 sites
    Other conditions: Osteoporosis, Steroid Induced
    View official trial listing →
  • Completed NCT NCT03051620

    Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate

    Aarhus University Hospital 142 participants Est. completion 2019-01-31 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT03197623

    Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids

    Not yet reported Nancy E. Lane, MD 58 participants Est. completion 2021-03-31 4 sites Stand-alone
    Other conditions: Osteopenia, Osteoporosis, Osteonecrosis
    View official trial listing →
  • Completed NCT NCT03204097

    Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2017-02
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT03292146

    Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2021-07-22 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Bone Density, Bone Loss, Eating Disorder
    View official trial listing →
  • Completed NCT NCT03396315

    Bisphosphonates for Prevention of Post-Denosumab Bone Loss

    Not yet reported Columbia University 24 participants Est. completion 2023-06-09 2 sites
    Other conditions: IOP, Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT03435094

    Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

    Labatec Pharma SA 80 participants Est. completion 2022-12-01 2 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT03542695

    64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

    Not yet reported City of Hope Medical Center 1 participants Est. completion 2024-05-31 1 site Stand-alone
    Other conditions: Breast Carcinoma, Calcification
    View official trial listing →
  • Active, not recruiting NCT NCT03623633

    Comparative Antiresorptive Efficacy Discontinuation of Denosumab

    Not yet reported Massachusetts General Hospital 51 participants Est. completion 2023-08-01 1 site
    Other conditions: Osteoporosis, Postmenopausal, Osteoporosis
    View official trial listing →
  • Active, not recruiting NCT NCT03692143

    Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

    Nanfang Hospital, Southern Medical University 90 participants Est. completion 2030-12-01
    Other conditions: Osteoporosis, Postmenopausal, Vertebral Fracture, Quality of Life
    View official trial listing →
  • Completed NCT NCT03980847

    Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket

    Not yet reported Islamic Azad University, Sanandaj 20 participants Est. completion 2019-04-25 1 site
    Other conditions: Bone Resorption
    View official trial listing →
  • Status unknown NCT NCT04140006

    Efficacy of Antiresorptive and Bone Forming Material on Dental Implants

    Not yet reported, Not yet reported University of Baghdad 20 participants Est. completion 2020-07-01 1 site
    Other conditions: Partial Edentulism
    View official trial listing →
  • Completed NCT NCT04169698

    Alendronate Versus Denosumab in Kidney Transplant Patients

    Not yet reported, Not yet reported Ain Shams University 90 participants Est. completion 2021-05-01 1 site Stand-alone
    Other conditions: Osteoporosis, Osteopenia, Renal Transplant Recipient
    View official trial listing →
  • Completed NCT NCT04177940

    Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot Study

    Not yet reported University of Alabama at Birmingham 45 participants Est. completion 2025-01-14 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT04338529

    Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation

    251 Hellenic Air Force & VA General Hospital 92 participants Est. completion 2024-11-01 1 site
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT04403698

    The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover

    Not yet reported University Hospital, Ghent 30 participants Est. completion 2022-03-09 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Status unknown NCT NCT04555317

    Bone Toxicity Following Pelvic Radiotherapy

    Not yet reported The Christie NHS Foundation Trust 80 participants Est. completion 2025-08 1 site
    Other conditions: Gynecologic Cancer, Radiotherapy Side Effect, Fracture
    View official trial listing →
  • Completed NCT NCT04708886

    Romosozumab in Women With Chronic SCI

    Not yet reported Northwestern University 12 participants Est. completion 2024-06-10 1 site Stand-alone
    Other conditions: Osteoporosis, Bone Loss, Osteopenia, Osteoporosis, Spinal Cord Injuries, Chronic Spinal Paralysis
    View official trial listing →
  • Status unknown NCT NCT04719572

    Intervention Study of Drugs in Patients Osteopenia and Osteoporosis

    Not yet reported Chinese PLA General Hospital 180 participants Est. completion 2023-01 1 site
    Other conditions: Osteoporosis, Osteopenia, Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT04739592

    A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis

    Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2024-07 3 sites Stand-alone
    Osteoarthritis
    View official trial listing →
  • Status unknown NCT NCT04861142

    Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy

    University General Hospital of Heraklion 350 participants Est. completion 2024-10 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT05091099

    The Optimal Sequential Therapy After Long Term Denosumab Treatment

    Not yet reported National Taiwan University Hospital 44 participants Est. completion 2025-11-14 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Active, not recruiting NCT NCT05151484

    Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover

    Not yet reported Madhumathi Rao 60 participants Est. completion 2027-01-31 1 site
    Other conditions: Age-Related Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT05162885

    Effect of Sodium Alendronate on the Final Implant Stability.

    Not yet reported Cairo University 24 participants Est. completion 2022-10-01 1 site
    Other conditions: Anterior Labial Wall Defect
    View official trial listing →
  • Status unknown NCT NCT05305183

    A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

    Not yet reported Shandong New Time Pharmaceutical Co., LTD 330 participants Est. completion 2024-05-31 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT05325515

    The Effect of Effervescent Alendronate on Bone Turnover

    Not yet reported Aarhus University Hospital 64 participants Est. completion 2022-12-01 1 site Stand-alone
    Other conditions: Osteopenia or Osteoporosis
    View official trial listing →
  • Completed NCT NCT05366621

    Post-fracture Medication and Mortality

    National Cheng-Kung University Hospital 216155 participants Est. completion 2021-10-31 1 site
    Other conditions: Osteoporosis, Osteoporosis Fracture, Drug Therapy, Mortality, Adherence, Medication
    View official trial listing →
  • Status unknown NCT NCT05387200

    Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis

    Not yet reported Yonsei University 170 participants Est. completion 2023-05 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT05397938

    Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis

    Not yet reported Shanghai JMT-Bio Inc. 231 participants Est. completion 2023-06-01 1 site Stand-alone
    Other conditions: Glucocorticoid Induced Osteoporosis
    View official trial listing →
  • Completed NCT NCT05493761

    Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

    Not yet reported Aristotle University Of Thessaloniki 72 participants Est. completion 2026-07-16 3 sites
    Other conditions: Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal
    View official trial listing →
  • Active, not recruiting NCT NCT05575167

    Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

    424 General Military Hospital 122 participants Est. completion 2027-11 9 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT05602493

    A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction

    Not yet reported Xeolas Pharmaceuticals Limited 60 participants Est. completion 2024-10-20 1 site
    Other conditions: Bone Loss, Alveolar
    View official trial listing →
  • Status unknown NCT NCT05645289

    Efficacy and Safety of Minodronate in Patients With Low Back Pain

    Not yet reported Peking University Third Hospital 72 participants Est. completion 2024-04-01 1 site
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT05662358

    Denosumab vs Alendronate After Vertebroplasty

    Not yet reported Shenzhen People's Hospital 90 participants Est. completion 2023-10-25 1 site
    Other conditions: Denosumab Allergy
    View official trial listing →
  • Status unknown NCT NCT05771038

    Assessment of Bone Quality After Socket Preservation Using Sodium Alendronate Gel Compared to Sticky Bone

    Not yet reported Cairo University 32 participants Est. completion 2023-07 1 site
    Other conditions: Bone Quality Assessment, Preserved Sockets, Sodium Alendronate, Sticky Bone
    View official trial listing →
  • Completed NCT NCT06264401

    Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis

    Not yet reported Cairo University 60 participants Est. completion 2024-06-02 1 site Stand-alone
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Enrolling by invitation NCT NCT06264609

    Precision Medicine Approach for Osteoporosis - Follow Up Study

    Not yet reported Paul F Netzel 40 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT06621069

    The Effect of Long-term Use of Bisphosphonates on Femur Morphology

    Second Affiliated Hospital, Zhejiang University, School of Medicine 140 participants Est. completion 2024-08-01 1 site
    Other conditions: Osteoporosis, Knee Osteoarthristis
    View official trial listing →
  • Completed NCT NCT06772792

    A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)

    Not yet reported Merck Sharp & Dohme LLC 36 participants Est. completion 2024-06-21 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT06856369

    Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic Periodontitis

    Not yet reported Bahria University 120 participants Est. completion 2027-09-30 1 site
    Other conditions: Alveolar Bone Loss Associated Chronic Periodontitis
    View official trial listing →
  • Withdrawn NCT NCT06973109

    Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

    Not yet reported University of Pittsburgh Est. completion 2027-06 1 site Stand-alone
    Other conditions: Osteoporosis, Post-menopausal
    View official trial listing →
  • Completed NCT NCT07028320

    To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 493 participants Est. completion 2024-05-20 1 site
    Other conditions: Postmenopausal Women With Osteoporosis
    View official trial listing →
  • Completed NCT NCT07242612

    Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

    Not yet reported Khyber Medical University Peshawar 40 participants Est. completion 2026-04-15 1 site
    Other conditions: Osteoporosis, Osteoporosis, Postmenopausal
    View official trial listing →
  • Not yet recruiting NCT NCT07245381

    Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

    Not yet reported, Not yet reported Dr. Itay GoorAryeh 65 participants Est. completion 2026-09 Stand-alone
    Other conditions: Cervix Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07471880

    A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

    Not yet reported ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. 161 participants Est. completion 2027-02-28 1 site
    Other conditions: Osteonecrosis, Osteonecrosis of the Femoral Head
    View official trial listing →
  • Enrolling by invitation NCT NCT07652372

    Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis

    Not yet reported ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. 60 participants Est. completion 2027-09-30 2 sites
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT07717788

    Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

    Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Osteoporosis, Postmenopausal, Statin Therapy
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Alendronate Sodium, Alendronate, Alendronate 70mg weekly

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.